Drugmaker to sell cheaper generic rival to EpiPen injectors

TRENTON, N.J. (AP) — A generic drugmaker plans to start selling a slightly cheaper version of the EpiPen in the U.S. early next year.

The penlike injectors are used to treat life-threatening allergic reactions. Brand-name EpiPen, which dominates the market, has been in short supply since spring because of production problems.

Drugmaker Sandoz said Thursday the price of two generic injectors will be $250 without insurance. Two other generics on the market in the U.S. cost $300 a pair. Brand-name EpiPens sold by Mylan cost at least twice as much.

The price people pay varies, though, depending on insurance and discounts.

Mylan was blasted in the past for price hikes that pushed the price over $600. It responded by selling its own generic.

SHARE

RELATED CONTENT

NFL agrees to settle collusion lawsuit with Kaepernick Missions holding baseball job fair ahead of 2019 season Tips to save on rising grocery costs Trump declares national emergency to build border wall 2020 Dems hit early voting states; Weld explores GOP bid Amazon’s exit could scare off tech companies from New York
Comments